Total Payments
$8,112
2024 Payments
$648.41
Companies
60
Transactions
352
Medicare Patients
13,965
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$7,162 (88.3%)
Other$780.00 (9.6%)
Education$120.29 (1.5%)
Consulting$50.00 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,162 | 338 | 88.3% |
| Honoraria | $700.00 | 4 | 8.6% |
| Education | $120.29 | 7 | 1.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $80.00 | 2 | 1.0% |
| Consulting Fee | $50.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $728.81 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $708.42 | 33 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $565.03 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $407.45 | 22 | $0 (2024) |
| Athenex Pharmaceutical Division, LLC | $350.00 | 2 | $0 (2021) |
| Janssen Biotech, Inc. | $318.28 | 17 | $0 (2023) |
| GENZYME CORPORATION | $309.61 | 9 | $0 (2024) |
| Genentech USA, Inc. | $296.81 | 21 | $0 (2019) |
| Amgen Inc. | $257.04 | 11 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $237.21 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $648.41 | 25 | Novartis Pharmaceuticals Corporation ($125.89) |
| 2023 | $935.44 | 37 | Integra LifeSciences Corporation ($153.35) |
| 2022 | $795.39 | 20 | Novocure GmbH ($200.00) |
| 2021 | $244.47 | 3 | Athenex Pharmaceutical Division, LLC ($175.00) |
| 2020 | $677.25 | 18 | Athenex Pharmaceutical Division, LLC ($175.00) |
| 2019 | $1,979 | 100 | Merck Sharp & Dohme Corporation ($275.09) |
| 2018 | $2,129 | 113 | Merck Sharp & Dohme Corporation ($287.14) |
| 2017 | $703.35 | 36 | Pharmacyclics LLC, An AbbVie Company ($117.64) |
All Payment Transactions
352 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $39.36 | General |
| Category: Oncology | ||||||
| 11/17/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $17.03 | General |
| Category: Hematology | ||||||
| 11/04/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $24.62 | General |
| Category: Prostate cancer | ||||||
| 10/07/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $37.17 | General |
| Category: Oncology | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $31.07 | General |
| 09/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $33.10 | General |
| Category: ONCOLOGY | ||||||
| 08/30/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Oncology | ||||||
| 08/26/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $23.12 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: ONCOLOGY | ||||||
| 08/05/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $31.79 | General |
| Category: Oncology | ||||||
| 07/03/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Oncology | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: Oncology | ||||||
| 06/07/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $44.83 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: ONCOLOGY | ||||||
| 05/01/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: ONCOLOGY | ||||||
| 03/20/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: ONCOLOGY | ||||||
| 02/29/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $17.76 | General |
| Category: Prostate cancer | ||||||
| 02/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Oncology | ||||||
| 02/06/2024 | E.R. Squibb & Sons, L.L.C. | AUGTYRO (Drug) | Food and Beverage | Cash or cash equivalent | $18.40 | General |
| Category: Oncology | ||||||
| 01/17/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $19.75 | General |
| 01/11/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 2,457 | 56,835 | $618,419 | $266,084 |
| 2022 | 52 | 4,020 | 102,448 | $1.0M | $436,984 |
| 2021 | 55 | 3,657 | 145,506 | $1.5M | $687,332 |
| 2020 | 60 | 3,831 | 137,934 | $1.2M | $543,831 |
Total Patients
13,965
Total Services
442,723
Medicare Billing
$1.9M
Procedure Codes
215
All Medicare Procedures & Services
215 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 19 | 3,540 | $103,620 | $65,183 | 62.9% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 37 | 45,750 | $91,500 | $39,939 | 43.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 178 | 292 | $60,216 | $25,181 | 41.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 60 | 273 | $102,810 | $24,570 | 23.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 64 | 158 | $44,456 | $20,600 | 46.3% |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | Office | 2023 | 17 | 51 | $28,422 | $17,900 | 63.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 298 | 844 | $15,381 | $8,698 | 56.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 306 | 935 | $14,043 | $7,799 | 55.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 296 | 947 | $13,544 | $7,155 | 52.8% |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 2023 | 18 | 77 | $5,390 | $5,782 | 107.3% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 39 | 226 | $19,210 | $4,611 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 75 | $10,880 | $4,130 | 38.0% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 20 | 70 | $13,020 | $3,114 | 23.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 44 | 71 | $13,135 | $3,053 | 23.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 98 | 173 | $4,434 | $2,277 | 51.4% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 16 | 42 | $8,820 | $2,121 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $4,662 | $1,958 | 42.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $4,446 | $1,778 | 40.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 16 | $3,008 | $1,417 | 47.1% |
| 83550 | Iron binding capacity | Office | 2023 | 93 | 167 | $2,685 | $1,409 | 52.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 40 | 125 | $8,375 | $1,254 | 15.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 25 | 61 | $5,150 | $1,238 | 24.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 20 | 72 | $2,088 | $1,185 | 56.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,436 | $1,063 | 43.7% |
| 83540 | Iron level | Office | 2023 | 93 | 167 | $1,975 | $1,043 | 52.8% |
About Dr. Rachel Mitchell, MD
Dr. Rachel Mitchell, MD is a Internal Medicine healthcare provider based in Shelbyville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2011. The National Provider Identifier (NPI) number assigned to this provider is 1992091995.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rachel Mitchell, MD has received a total of $8,112 in payments from pharmaceutical and medical device companies, with $648.41 received in 2024. These payments were reported across 352 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($7,162).
As a Medicare-enrolled provider, Mitchell has provided services to 13,965 Medicare beneficiaries, totaling 442,723 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 215 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Shelbyville, TN
- Active Since 06/28/2011
- Last Updated 04/10/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1992091995
Products in Payments
- KEYTRUDA (Biological) $688.71
- OPDIVO (Biological) $262.34
- IMFINZI (Drug) $237.18
- GILOTRIF (Drug) $212.90
- ELITEK (Drug) $206.47
- Imbruvica (Drug) $158.32
- Kerecis Omega3 Wound (Device) $156.00
- XTANDI (Drug) $154.73
- Integra (Device) $153.35
- Ultomiris (Drug) $150.00
- KISQALI (Drug) $144.78
- XPOVIO (Drug) $143.62
- CALQUENCE (Drug) $141.13
- TAGRISSO (Drug) $130.32
- Pomalyst (Drug) $124.99
- REGRANEX (Drug) $116.78
- Neulasta (Biological) $116.07
- BENDEKA (Drug) $96.03
- Nexavar (Drug) $95.04
- Lenvima (Drug) $94.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Shelbyville
Stina Wedlock, Md, MD
Internal Medicine — Payments: $4,544
Internal Medicine $4,544
Nancy Miles, Md, MD
Internal Medicine — Payments: $1,267
Internal Medicine $1,267
Dr. Karim Jacob, Md, MD
Internal Medicine — Payments: $1,085
Internal Medicine $1,085
Dr. Amandeep Aulakh, M.d, M.D
Internal Medicine — Payments: $678.83
Internal Medicine $678.83
Gregory Pfister, M.d, M.D
Internal Medicine — Payments: $505.48
Internal Medicine $505.48
Thomas Nedumthottathil, M.d, M.D
Internal Medicine — Payments: $213.22
Internal Medicine $213.22